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Abstract
Introduction Cavernous hemangiomas represent the most common benign primary hepatic neoplasm, often being
incidentally detected. Although the majority of hepatic hemangiomas remain asymptomatic, symptomatic hepatic
hemangiomas can present with abdominal pain, hemorrhage, biliary compression, or a consumptive coagulopathy. The
optimal surgical management of symptomatic hepatic hemangiomas remains controversial, with resection, enucleation, and
both deceased donor and living donor liver transplantation having been reported.
Case Report We report the case of a patient found to have a unique syndrome of multiorgan cavernous hemangiomatosis
involving the liver, lung, omentum, and spleen without cutaneous involvement. Sixteen years following her initial diagnosis, the
patient suffered from intra-abdominal hemorrhage due to her giant cavernous hepatic hemangioma. Evidence of continued
bleeding, in the setting of Kasabach-Merritt Syndrome and worsening abdominal compartment syndrome, prompted MELD
exemption listing. The patient subsequently underwent emergent liver transplantation without complication.
Conclusion Although cavernous hemangiomas represent the most common benign primary hepatic neoplasm, hepatic hemangioma
rupture remains a rare presentation in these patients. Management at a center with expertise in liver transplantation is warranted for
those patients presenting with worsening DIC or hemorrhage, given the potential for rapid clinical decompensation.
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Introduction
Cavernous hemangiomas represent the most common
benign primary hepatic neoplasm, with a reported preva-
lence of 3% to 20% based upon autopsy series.
1 These
congenital vascular malformations are microscopically
composed of cavernous vascular channels that are lined
by single layers of flattened endothelium separated by
fibrous septae. The majority of hepatic hemangiomas are
less than 5 cm in size, solitary, and rarely symptomatic.
There is a reported female-to-male ratio of up to 6:1, and
most hepatic hemangiomas frequently present within the
fourth to fifth decade of life. In 1970, Adam et al. reported
a series of 106 hemangioma resections over a 30-year
period and delineated hemangiomas >4 cm as “giant”.
2
Giant hepatic hemangiomas represent <10% of all hepatic
hemangiomas.
3 We describe here a report of emergent liver
transplantation for a ruptured giant hepatic hemangioma in
a patient with a unique syndrome of multiorgan cavernous
hemangiomatosis.
Case Report
In September of 2003, a 32-year-old Caucasian female
presented to an outside institution with a chief complaint
of increasing abdominal fullness for 2 months. The
patient reported mild abdominal discomfort during her
daily activities, as well as decreased appetite and early
satiety. Her past medical history was significant for an
incidentally diagnosed liver mass in 1994 when she had
undergone an abdominal computed tomographic (CT)
scan as part of a workup for amenorrhea. At that time,
the 10-cm well-marginated hypodense mass in the right
lobe of the liver was confirmed to be a hemangioma by
subsequent nuclear scan, and no further treatment was
initiated. On her subsequent presentation in 2003, the
patient was found to have massive hepatomegaly and
thus underwent laparoscopic biopsy of the hepatic lesion.
Pathology revealed a benign cavernous hemangioma, and
the patient was then transferred to our institution for
further evaluation.
On admission, the patient's laboratory values were
notable for a total bilirubin of 2.1 mg/dL (normal range,
0.3–1.3) and an international normalized ratio (INR) of 1.4.
Serum tumor markers were all within normal limits. CT
scan of the abdomen and chest showed numerous, large
hypervascular liver masses, the largest measuring 18×
23 cm (Fig. 1a), splenic hemangiomas, as well as
innumerable bilateral pulmonary nodules (Fig. 1b). Given
the multiorgan presentation raising concern for a metastatic
neoplasm, the patient underwent video-assisted thoraco-
scopic surgery which demonstrated diffuse, purple, raised,
subpleural nodules (Fig. 1c). The lung biopsy demonstrated
pulmonary cavernous hemangiomas (Fig. 1d). Additional
stains for both CD34 and CD31 highlighted the benign
endothelial cell lining of the vascular spaces. In addition,
HMB-45 staining was negative, ruling out lymphangioleio-
myomatosis. The patient was discharged from the hospital
and started on interferon alpha-2b in an attempt to shrink
her hepatic and pulmonary lesions; this resulted in mild
radiological and symptomatic improvement. Given the size
and number of her lesions, it was felt that curative liver
resection was not technically possible and that ultimately
she might require liver transplantation. The patient was
listed for transplantation, but over the ensuing years she
remained stable.
In January of 2010, the patient developed severe mid-
abdominal pain while riding a horse. She subsequently
suffered a syncopal episode and was taken to the
emergency room where she was found to be hypotensive
with a hematocrit of 22%. She was transfused 4 units of
blood and transferred to our facility. On arrival, she was
in no distress and hemodynamically stable. Her exam
was significant for markedly increased abdominal disten-
sion (Fig. 2a). Her admission weight was 84 kg. Labora-
tory values demonstrated a hematocrit of 24.6%, INR of
2.1, fibrinogen of 78 mg/dL, platelets of 99,000×10
6/L
(decrease from her baseline of 180,000×10
6/L), creatinine
of 0.61 mg/dL, and a total bilirubin of 4.4 mg/dL. Her
admission Model for End-Stage Liver Disease (MELD)
score was 20. A CT scan demonstrated a large amount of
intra-peritoneal blood in addition to the known hepatic
hemagiomas. Over the course of the subsequent 48 h, her
abdominal distension worsened, and she developed pro-
gressive lower extremity edema. Despite resuscitation
with blood products, as well as the use of aminocaproic
acid, she continued to demonstrate a consumptive coagul-
opathy with evidence of ongoing bleeding. Her abdominal
compartment syndrome worsened, with evidence of
decreased urinary output and rising creatinine levels. A
petition to the United Network for Organ Sharing
Regional Review Board requesting a high initial MELD
to ensure life-saving emergent transplantation was sub-
mitted and approved.
On hospital day 14, a suitable donor became available.
The recipient was brought to the operating room and
explored. Four liters of old blood, with no evidence of
clot, were evacuated. There were no immediate signs of
active bleeding. The liver occupied her entire abdomen,
the majority of which showed the appearance of a
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contained innumerable berry-sized hemangiomas. The
patient had a conventional main hepatic artery, as well as
replaced right and left hepatic arteries. These were
individually ligated and divided. Clamps were then placed
on the supra-hepatic inferior vena cava (IVC), infra-
hepatic IVC, and portal vein. The liver was then drained
of a large volume of blood to facilitate the completion of
the posterior dissection under improved visualization. The
liver was excised (Fig. 2c), and the donor allograft was
brought to the operative field. A bicaval anastomosis,
followed by a portal vein anastomosis, was performed.
Given the small caliber size of each of the recipient's
hepatic arteries, the arterial anastomosis was done directly
to the supraceliac aorta. Biliary drainage was achieved by
choledochocholedochostomy. Following completion of the
liver transplant (Fig. 2d), the patient was extubated in the
operating room and transferred to the intensive care unit.
She was subsequently transferred to the transplant ward on
post-operative day 1 and discharged home on post-
operative day 11 following an uneventful post-operative
course. On outpatient follow-up, the patient remains well
and has begun to resume a normal level of activity.
The patient's weight at the time of discharge was 46 kg, a
net loss of 38 kg from her pre-transplant weight. Histological
examination of the liver revealed multiple areas of dilated
blood-filled spaces lined by a layer of flattened endothelial
cells, thus confirming the diagnosis of cavernous hepatic
hemangioma. These changes occupied the entire right lobe
and the majority of the left lobe of the liver.
Discussion
The majority of hepatic hemangiomas are asymptomatic and
require no intervention. Indeed, advances in imaging technol-
ogy, as well as the widespread application of diagnostic
imaging,hasresultedinthemorefrequentdetectionofhepatic
hemangiomas.
4 For those with symptomatic lesions, right
upper quadrant pain or fullness is the most common
complaint. Whereas 40% of patients with 4-cm hemangio-
mas are symptomatic, 90% of patients with 10-cm heman-
giomas are symptomatic.
5 Giant hemangiomas can present
with abdominal fullness or pain, hemorrhage within the
hemangioma or within the abdominal cavity with associated
hemodynamic compromise, jaundice due to compression of
the biliary tree, cardiac failure from massive arteriovenous
shunting, or as a consumptive coagulopathy (Kasabach-
Merritt Syndrome). The latter syndrome of profound
thrombocytopenia, microangiopathic hemolytic anemia, a
consumptive coagulopathy, and an enlarging vascular lesion
was first reported in 1940 as a case of thrombocytopenic
purpura in a 2-month-old child who presented with a rapidly
growing cutaneous hemangioma.
6
The optimal surgical management of giant hepatic heman-
giomas remains controversial with resection, enucleation, and
Fig. 1 a Initial abdominal CT at
presentation in 2003 showing
the largest lesion
(18.1×15.9 cm) measured at
level of the right portal vein and
the second largest lesion was
4.3×3.5 cm. b Initial chest CT
in 2003 revealing innumerable
pulmonary nodules.
c Video-assisted thoracoscopic
surgery (VATS). Diffuse
hemorrhagic, purple/red, raised
nodules are seen on the surface
of the lung. Biopsy of these
lesions revealed benign
cavernous hemangiomas.
d Photomicrograph of an
H&E-stained section of
cavernous hemangioma in a
lung biopsy specimen (40×).
The lung lesions were small and
well-circumscribed with benign
endothelial cells and thin vessel
walls and septa composed
predominantly of fibrous tissue.
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having been reported.
7–13 Surgical resection or enucleation
has often been reserved for symptomatic, single-lobe lesions.
Symptomatic patients with unresectable lesions, multiple bi-
lobar hemangiomas, or those involving the hepatic hilum,
have often been referred for consideration for liver trans-
plantation. Our patient's clinical course was unique as she
was monitored for years without change in clinical presen-
tation and without limitations in her daily activities.
Furthermore, the size and diffuse nature of her hepatic
hemangiomas precluded liver resection. Consideration for
living donor liver transplant prior to her acute presentation
was deferred given her continued stability as an outpatient.
Furthermore, our patient's rapid decline following presenta-
tion prevented the ability for timely living donor evaluation
and thus required petition for MELD exemption to allow for
emergent liver transplantation. Patients with hepatic heman-
giomas who present with evidence of worsening DIC and/or
hemorrhage should be referred emergently to centers with
expertise in liver transplantation, given the potential for rapid
decompensation.
Although previous reports on liver transplantation for giant
hepatichemangiomashavedocumentedreversalofKasabach-
Merritt Syndrome,
7–13 we believe this to be the first report of
transplantation in the setting of hemorrhage from a giant
hepatic hemangioma. Rupture of a hepatic hemangioma
remains an extremely rare event, with a reported incidence of
1% to 4%
14 and a reported high rate of mortality (60–
75%).
15 A report from 2003 identified 32 published cases of
spontaneous hepatic hemangioma rupture in adults, of which
27 cases were available for review.
16 In the latter study, the
mean hemangioma size was 14.8 cm. Four of the 27 patients
died from hemorrhage without surgical intervention. Twenty-
two of the remaining 23 patients underwent surgery (59%
resection, 23% suture ligation, and 18% tamponade). Trans-
catheter arterial embolization was undertaken in 31% of
patients prior to hepatic resection. Mortality for the different
forms of surgical interventions was 23% for resection, 40%
for suture ligation, and 75% for tamponade, with an overall
mortality of 36%.
16 There were no documented cases of
hepatic hemangioma rupture managed with emergent liver
transplantation.
Non-surgical treatment of giant hepatic hemangiomas in
stable patients has been reported with mixed results and
includes interferon administration, transarterial catheter
embolization, and hepatic radiation therapy. Interferon has
known anti-angiogenic properties, and a few case reports
have described its efficacy in the treatment of vascular
malformations and neoplasms.
17 Our patient demonstrated
minimal symptomatic and radiological improvement with
Fig. 2 a Intra-operative photo
prior to start of liver
transplantation demonstrating
the patient's massive abdominal
distension. b Giant cavernous
hepatic hemangioma occupying
the entire abdominal cavity.
c Posterior aspect of gross liver
specimen following resection
and complete decompression
(the white ruler on the specimen
measures 15 cm in length and is
on top of the left lobe).
d Intra-operative photo at the
completion of liver
transplantation demonstrating
the patient's abdomen.
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reported radiotherapy as an effective means to limit or
regress hemangioma growth, as well as decrease associated
symptoms. Radiotherapy has often been administered at a
dose ranging from 15 to 30 Gy in 15 to 22 fractions over a
few weeks with minimal morbidity.
18,19 It should be noted
that the efficacy of radiation therapy in reversing the DIC
associated with Kasabach-Merritt Syndrome has yet to be
demonstrated. Hepatic arterial embolization has been
reported to be the second most common form of treatment
of symptomatic giant hemangiomas, with surgical resection
being the most common.
20 Transarterial embolization has
been reported to provide symptomatic relief, as well as a
reduction in hemangioma size.
21,22 Indeed, the ability to
perform catheter-directed therapy has circumvented the
need for open hepatic artery ligation as a form of
management for hepatic hemangiomas. However, the role
of transarterial catheter embolization in the management of
cavernous hepatic hemangiomas in the setting of Kasabach-
Merritt Syndrome remains limited.
23 Complications associ-
ated with embolization include liver infarction with
associated abscess formation, as well as treatment failure
associated with vessel recanalization following emboliza-
tion.
7 Superselective arterial embolization has been used for
patients with hemorrhage from hepatic hemangioma rup-
ture; however, this modality has been employed as a bridge
to successful hepatic resection, rather than as a permanent
treatment for ongoing hemorrhage.
24
Conclusion
Herein, we describe a patient with massive hepatomegaly
found to have what appears to be a unique syndrome of
multiorgan cavernous hemangiomatosis of the liver, lung,
omentum, and spleen without cutaneous involvement.
Although the majority of hepatic hemangiomas remain
asymptomatic, and thus require no intervention, symptom-
atic focal lesions can be addressed surgically by either
enucleation or resection. More extensive symptomatic
disease, as demonstrated in our patient, necessitates liver
transplantation. Our patient suffered from ongoing intra-
abdominal hemorrhage in the setting of Kasabach-Merritt
Syndrome, with associated abdominal compartment syn-
drome. Her continued clinical decompensation required
MELD exemption listing and thus allowed for emergent
liver transplantation.
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